An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
about
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alphaS32/36A repressor of NF-kappaBAnti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypesPhysical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle.Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoproteinBiocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integrationNF-κB as a potential therapeutic target in microbial diseases.The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development.The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency.Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappaB.Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNA
P2860
Q24802730-F8C32295-1765-4580-944B-14CEB00975E4Q30349885-FD001D8A-E1CD-4B71-9F9D-961CBEB4C12DQ30428712-F2003E0F-1143-49BE-9E99-C590415D4B10Q31072762-560E270B-FFBD-4163-A1AC-52B38B6B642FQ33587139-EDBCE563-AAA4-48E5-8AF7-AC9FC114BB86Q33613718-36A1E9A8-F85E-44E4-82F4-B01213634669Q34352092-57C45816-D64D-407D-B28E-BA66744EB84DQ34994374-8E384782-6651-4978-BF71-36AE60E3F714Q35215392-DF435F17-6027-42FA-92D4-3A65CDF9B5F5Q36313032-F257A309-20E0-4F5E-9E0C-3313A43AA878Q36684330-D72FDFAA-8C34-474D-9797-EABF0C193F26Q37981941-BE9226D7-9666-4EC8-8B65-FE3CF22DBBE8Q38298916-94CC2185-0D49-4151-B20D-B554D9AD5858Q40949172-131B1E06-E797-4A3F-9432-587513463874Q42117931-5FCAC549-340E-41B0-97F5-6E6FFA731411Q44884891-047B6517-1F67-4C14-BAF1-0F6583286841Q45710556-19065FCE-31FB-4588-9AAB-796C2F24C2FFQ58800504-380B3CD7-2B99-49F9-AD92-7B3740F2478C
P2860
An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
An NF-kappaB site in the 5'-un ...... NF-kappaB-activating stimuli.
@en
type
label
An NF-kappaB site in the 5'-un ...... NF-kappaB-activating stimuli.
@en
prefLabel
An NF-kappaB site in the 5'-un ...... NF-kappaB-activating stimuli.
@en
P2093
P2860
P356
P1476
An NF-kappaB site in the 5'-un ...... o NF-kappaB-activating stimuli
@en
P2093
C Ambrosino
E Dragonetti
F Baldassarre
P2860
P304
20820-20827
P356
10.1074/JBC.271.34.20820
P407
P577
1996-08-01T00:00:00Z